USPTO 2015–2025 USPTO PatentsView Foreign Corporation

LUPIN LIMITED

USPTO PatentsView assignee record — 106 granted patents across 21 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

106
Total patents granted
21
CPC technology areas
14.7
Avg claims per patent
-46%
5-year filing velocity

Portfolio overview

LUPIN LIMITED has been granted 106 US utility patents between 2015 and 2025, placing LUPIN LIMITED at rank #3,480 across all assignees tracked by PlainPatent. This portfolio spans 21 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.7 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, LUPIN LIMITED is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 45.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 37 grants, compared with 69 in the 2015–2019 window — a -46% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. LUPIN LIMITED's 14.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 21 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark LUPIN LIMITED against peers pursuing similar technology classes.

How does LUPIN compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows LUPIN holds 106 patents — placing it at rank #3,480 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

0510152025 20152016201720182019202020212022202320242025 6
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
LUPIN LIMITED patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 21 19.8%
2016 13 12.3%
2017 12 11.3%
2018 13 12.3%
2019 10 9.4%
2020 10 9.4%
2021 4 3.8%
2022 12 11.3%
2023 3 2.8%
2024 2 1.9%
2025 6 5.7%

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#3,480

Across all tracked assignees

Innovation Score

45.9 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does LUPIN LIMITED hold?
LUPIN LIMITED holds 106 US granted patents filed between 2015 and 2025, spanning 21 technology areas.
What is LUPIN LIMITED's Innovation Score?
LUPIN LIMITED has an Innovation Score of 45.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does LUPIN LIMITED focus on?
LUPIN LIMITED's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 66 patents. The company has filed patents in 21 CPC subclasses total.
Is LUPIN LIMITED's patent filing rate increasing or decreasing?
LUPIN LIMITED's recent filing velocity is -46% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for LUPIN LIMITED's patents?
LUPIN LIMITED's patents average 14.7 claims each. This falls within the standard range, providing solid legal coverage.
How is the LUPIN LIMITED patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope